{"version":"1.0","provider_name":"Biocontrol Technologies","provider_url":"https:\/\/biocontroltechnologies.com\/en\/","author_name":"Adri\u00e1 Peremiquel Trillas","author_url":"https:\/\/biocontroltechnologies.com\/en\/author\/admin-adria\/","title":"Completion of the CDTI-funded project | Biocontrol Technologies","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"4kcUaNePsX\"><a href=\"https:\/\/biocontroltechnologies.com\/en\/2026\/02\/26\/completion-of-the-cdti-funded-project\/\">Completion of the CDTI-funded project<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/biocontroltechnologies.com\/en\/2026\/02\/26\/completion-of-the-cdti-funded-project\/embed\/#?secret=4kcUaNePsX\" width=\"600\" height=\"338\" title=\"&#8220;Completion of the CDTI-funded project&#8221; &#8212; Biocontrol Technologies\" data-secret=\"4kcUaNePsX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/biocontroltechnologies.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/biocontroltechnologies.com\/wp-content\/uploads\/2023\/11\/CDTI.jpg","thumbnail_width":1536,"thumbnail_height":934,"description":"Biocontrol Technologies completes its CDTI-funded R&amp;D project Facebook Twitter LinkedIn In 2023, the Centre for the Development of Industrial Technology (CDTI) approved funding for the company\u2019s project entitled \u201cNew developments and applications of the active substance Trichoderma asperellum, strain T34.\u201d The project had a total budget of \u20ac369,310.00 and received partially repayable funding with interest [&hellip;]"}